European panel supports Genzyme's Myozyme facility

02/20/2009 | Boston Globe (tiered subscription model), The

A committee of the European Commission issued a positive opinion regarding Genzyme's application to produce and market Pompe disease drug Myozyme at a Belgian manufacturing plant. The European Commission will make a final decision based on the opinion of the Committee for Medicinal Products for Human Use.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC